Allergy Treatment Options

Matching Treatment to Allergy Type and Goals

Allergy treatment is not universal. The right approach depends on the type of allergy, the severity of symptoms, which organ systems are affected, your health history, and your goals for long-term management. Treatment falls into four broad categories: exposure reduction, symptom-relief medications, prescription therapies for more severe or refractory cases, and disease-modifying allergen immunotherapy. Understanding these distinctions helps in choosing between guides.

Exposure Reduction

Avoiding or minimizing contact with identified allergens reduces the immune burden and can improve medication effectiveness. For environmental allergies this includes encasements for dust mite control, air filtration, and pollen avoidance during peak periods. For food allergies, strict avoidance remains the primary management strategy. Our allergy prevention guide and allergy-friendly home guide cover source-specific reduction strategies.

Oral Antihistamines

Second-generation oral antihistamines — cetirizine, loratadine, fexofenadine — are appropriate first-line options for mild-to-moderate allergic rhinitis, urticaria, and eye symptoms. They relieve sneezing, itching, and rhinorrhea quickly and are suitable for daily use. First-generation antihistamines such as diphenhydramine cause significant sedation and cognitive impairment and are not recommended for regular use. Our antihistamines comparison guide evaluates the evidence across specific products including drug interactions and dosing considerations.

Nasal and Ocular Treatments

Intranasal corticosteroid sprays — fluticasone, mometasone, budesonide — are now considered first-line for persistent allergic rhinitis by major allergy societies, outperforming antihistamines for nasal congestion. Several are available over the counter. For eye symptoms, topical antihistamine-mast cell stabilizer eye drops offer targeted relief. Our nasal spray treatment guide explains correct technique, since improper use is a common reason for inadequate response.

Asthma Overlap

Approximately 80% of people with asthma have an allergic component. When allergic rhinitis and asthma coexist — as they often do — treating nasal disease can improve asthma control. Leukotriene receptor antagonists such as montelukast (Singulair) address both conditions simultaneously, though the FDA has added labeling about neuropsychiatric effects that warrant discussion before prescribing. Patients with both conditions benefit from coordinated evaluation by an allergist.

Prescription Options for Moderate to Severe Disease

When OTC options are insufficient, prescription treatments offer additional leverage. These include prescription-strength intranasal therapies, combination nasal sprays, and leukotriene modifiers. Our prescription allergy treatments guide covers evidence and appropriate use cases for each category.

Biologic Medications

Biologics target specific immune pathways rather than broadly suppressing inflammation. Omalizumab (Xolair) blocks free IgE and is approved for chronic urticaria and allergic asthma. Dupilumab (Dupixent) blocks IL-4 and IL-13 and is approved for moderate-to-severe atopic dermatitis, asthma, and certain nasal conditions. These agents represent a significant advance for patients with severe, treatment-resistant allergic disease. Our biologic allergy medications guide explains mechanism, indication, and what to expect during treatment.

Allergen Immunotherapy

Allergen immunotherapy (AIT) is the only treatment that modifies the underlying allergic immune response rather than just managing symptoms. Administered as subcutaneous injections (SCIT), sublingual tablet or drop (SLIT), or orally for food allergy (OIT), AIT progressively shifts the immune response away from IgE-mediated reactivity. Responses are often sustained years after a full course is completed. It is most clearly indicated for patients with significant environmental allergies whose symptoms are inadequately controlled by medications alone.

Emergency Medication

Epinephrine is the only first-line treatment for anaphylaxis. Antihistamines and corticosteroids are insufficient as primary anaphylaxis treatment. Anyone with a history of severe allergic reactions should carry two epinephrine auto-injectors and have a written emergency action plan. Anaphylaxis can occur even in patients who have only experienced mild reactions previously — prior mild reaction does not reliably predict future mild reaction.

Food Allergy Management

Food allergy management differs from environmental allergy management. The primary strategy is strict allergen avoidance combined with label-reading skill, emergency preparedness with epinephrine, and a written allergy action plan. For select patients with peanut allergy — primarily children — oral immunotherapy (OIT) under medical supervision can raise the reaction threshold. Food allergy management requires ongoing specialist coordination rather than self-management.

Children and Pregnancy

Treatment decisions in children require attention to age-appropriate dosing and long-term safety evidence. Most antihistamines and nasal corticosteroids have well-established pediatric profiles. During pregnancy, medication selection is guided by established safety categories. Most intranasal corticosteroids are considered low risk, while systemic decongestants warrant caution especially in the first trimester. Immunotherapy can typically be continued but not initiated during pregnancy. Always discuss medication decisions with the prescribing clinician during pregnancy.

When Self-Care Is Insufficient

OTC antihistamines and nasal sprays are appropriate starting points for mild symptoms but have clear limits. Seek specialist input when symptoms significantly affect sleep, school, or work performance; when you have had a severe allergic reaction; when you develop lower respiratory symptoms; or when you have multiple coexisting allergic conditions. A board-certified allergist can perform definitive testing, optimize your treatment regimen, and determine whether immunotherapy or biologic therapy is appropriate for your situation.

All Articles in This Silo